NCT00411398View on ClinicalTrials.gov

A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
General Anxiety Disorder, Social Anxiety Disorder
Interventions
DRUG

Namenda/Memantine

5mg tablets, 1-4 tabs by mouth per day

Trial Locations (1)

13210

SUNY Upstate Medical University Psychiatry Dept., Syracuse

All Listed Sponsors
lead

State University of New York - Upstate Medical University

OTHER

NCT00411398 - A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder | Biotech Hunter | Biotech Hunter